Aripiprazole and Atomoxetine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aripiprazole (aripiprazole) and Atomoxetine (atomoxetine). Common drug interactions include dry eye among females and irritability among males.
The phase IV clinical study analyzes what interactions people have when they take Aripiprazole and Atomoxetine. It is created by eHealthMe based on reports of 109 people who take the same drugs from the FDA, and is updated regularly.
What is Aripiprazole?
Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.
What is Atomoxetine?
Atomoxetine has active ingredients of atomoxetine. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,363 Atomoxetine users. Check the latest studies of Atomoxetine.
109 people who take Aripiprazole and Atomoxetine together, and have interactions are studied.
What are the common drug interactions of Aripiprazole and Atomoxetine, by gender? *
What are the common drug interactions of Aripiprazole and Atomoxetine, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Aripiprazole and Atomoxetine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Aripiprazole (39,143 reports)
- Atomoxetine (1,363 reports)
Browse all drug interactions of Aripiprazole and Atomoxetine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aripiprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Atomoxetine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aripiprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Atomoxetine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole and atomoxetine (the active ingredients of Aripiprazole and Atomoxetine, respectively), and Aripiprazole and Atomoxetine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Theophylline cause Atherosclerosis? - a second ago
- Gout and Sepsis - 6 seconds ago
- Could Uptravi cause Rectal Tenesmus? - 8 seconds ago
- Panic Disorder and Tremor Aggravated - 8 seconds ago
- Could Ilaris cause Dizziness? - 21 seconds ago
- Could Norco cause Erythema Multiforme? - 27 seconds ago
- Could Zopiclone cause Leukopenia? - 35 seconds ago
- Drug interactions of Menatetrenone and Rabeprazole Sodium - 40 seconds ago
- Could Vitrakvi cause Pain Exacerbated? - 41 seconds ago
- Could Pegintron cause Pathogen Resistance? - 44 seconds ago